NCT06854913

Brief Summary

Goal: The clinical investigation aims to evaluate the impact of orthopedic shoulder surgery on sleep quality and functional recovery in workers with shoulder musculoskeletal disorders. This will be assessed through validated questionnaires and physiological monitoring using wearable sensors. Participant Population: The study will enroll at least 30 participants diagnosed with shoulder musculoskeletal disorders, such as rotator cuff tears, adhesive capsulitis, and glenohumeral osteoarthritis. Participants must be employed in physically demanding jobs that require frequent upper limb activity and are scheduled for orthopedic shoulder surgery. Main Questions:

  • How does post-operative rehabilitation influence sleep quality and functional recovery in workers with shoulder musculoskeletal disorders?
  • To what extent does post-operative rehabilitation improve pain management and overall quality of life in these patients?
  • How do patients perceive the usability and comfort of wearable sensors during their rehabilitation process? Participant Tasks:
  • Initial Assessment: Comprehensive clinical evaluation, including demographic and anthropometric data collection, and administration of the Pittsburgh Sleep Quality Index (PSQI).
  • Wearable Sensor Training: Instruction on the proper use of the Medtronic Zephyr BioPatch™ wearable biosensor for monitoring physiological and postural signals.
  • Sleep Monitoring: Participants will undergo sleep assessments at three key time points: Two nights before surgery (baseline measurement); Two weeks post-surgery during early rehabilitation; 30 days into the rehabilitation program.
  • Daily Logging: Completion of the Consensus Sleep Diary each morning following sensor use.
  • Functional Assessment: Objective evaluation of shoulder functionality through validated clinical scales and range of motion (ROM) assessments.
  • Pain and Usability Evaluation: Measurement of pain reduction and usability of wearable technology using Patient-Reported Outcome Measures (PROMs).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Mar 2025Jun 2026

First Submitted

Initial submission to the registry

February 12, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

March 3, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

1.2 years

First QC Date

February 12, 2025

Last Update Submit

May 19, 2025

Conditions

Keywords

Musculoskeletal disordersShoulder painSleep MonitoringOrthopedic Surgery OutcomesWearable Sensors

Outcome Measures

Primary Outcomes (6)

  • Heart Rate Evaluation During Sleep Across Different Rehabilitation Phases

    Heart rate will be monitored using wearable sensors during sleep across different rehabilitation phases. It will be recorded in beats per minute to evaluate the physiological response to recovery and adaptation throughout the rehabilitation process.

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  • Respiratory Rate Evaluation Evaluation During Sleep Across Different Rehabilitation Phases

    Respiratory rate will be monitored using wearable sensors during sleep across different rehabilitation phases. It will be recorded in breaths per minute to assess the physiological response to recovery and adaptation throughout the rehabilitation process

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  • Change in Sleep Efficiency Across Different Rehabilitation Phases

    Sleep efficiency is defined as the percentage of total sleep time (TST) relative to the total time spent in bed (sleep opportunity). It is calculated by dividing the amount of time spent asleep by the total time in bed and multiplying by 100. This measurement will be obtained using wearable sensors. Values of 85% or higher are generally considered indicative of good sleep quality. This parameter is critical for assessing how effectively the available time for sleep is used and for identifying sleep fragmentation or disruptions.

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  • Change in Sleep Duration Across Different Rehabilitation Phases

    Sleep duration refers to the total amount of time a subject spends asleep during the night, expressed in minutes or hours. It is measured from the onset of sleep until the final awakening, excluding periods of wakefulness. The wearable device continuously tracks sleep and wake states, providing an accurate account of total sleep time. For adults, a duration of 7 to 9 hours is typically recommended. Monitoring sleep duration is essential to evaluate the restorative quality of sleep and to compare changes across different rehabilitation phases.

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  • Change in Wake After Sleep Onset (WASO) Across Different Rehabilitation Phases

    WASO is defined as the total time, in minutes, that a subject remains awake after the initial onset of sleep and before the final awakening. A wearable device records all episodes of wakefulness during the sleep period and sums them to calculate WASO. A WASO value of less than 30 minutes is generally considered normal for healthy sleep. Elevated WASO values can indicate increased sleep fragmentation, which may compromise the quality of sleep.

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  • Change in Sleep Latency Across Different Rehabilitation Phases

    Sleep latency is the duration, measured in minutes, between the moment a subject goes to bed (or turns off the lights) and the onset of sleep. The wearable device identifies the sleep onset as the first epoch classified as sleep. A sleep latency of less than 20 minutes is generally considered normal, whereas prolonged sleep latency may signal difficulties in initiating sleep, possibly due to pre-surgical anxiety or post-surgical discomfort.

    three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

Secondary Outcomes (4)

  • Change in Sleep Data among different rehabilitation phases

    Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  • Evaluation of the usability and Comfort of Wearable Technology

    Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  • Evaluation of the Objective Improvement in Shoulder Functionality

    Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  • Evaluation of the Reduction in Pain Levels among different rehabilitation phases

    Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

Study Arms (1)

Workers with shoulder musculoskeletal disorders

EXPERIMENTAL

Workers with shoulder musculoskeletal disorders will be enrolled from the Unit of Traumatology and Sports Medicine of FPUCBM. Patients who meet the inclusion criteria will be provided with an explanation of the study and the experimental protocol. After consenting to participate in the study and signing the informed consent, demographic and anthropometric data will be collected and registered on a database shared among authorized investigators involved in the project. In addition, patients will receive detailed verbal and written instructions on how to use the Medtronic Zephyr BioPatch™ wearable biosensor (Medtronic, Inc., Annapolis, MD, USA) for sleep monitoring. They will also be trained on how to complete the Consensus Sleep Diary, which they will fill out each morning after using the sensor. Sleep monitoring will be conducted at three key time points to assess changes in sleep patterns during the study. The first assessment will occur over two consecutive nights prior to surgery,

Other: Post-Operative monitoring using wearable biosensorOther: Usability Assessment and Patient Willingness to Use Technology Description

Interventions

The protocol involves the use of the Medtronic Zephyr BioPatch™, a wearable biosensor, to monitor sleep quality and patterns in patients recovering from shoulder surgery. The device tracks physiological signals (ECG, HRV, respiratory rate) and postural changes, providing objective data on sleep profiles. Patients are assessed at three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase). The primary goal is to evaluate changes in sleep quality and patterns during the post-operative period, while also monitoring improvements in shoulder functionality and pain levels. This approach aims to provide insights into the relationship between sleep quality and recovery outcomes following shoulder surgery.

Workers with shoulder musculoskeletal disorders

The usability of the Medtronic Zephyr BioPatch™ is evaluated through patient feedback and questionnaires, focusing on comfort, ease of use, and reliability. Additionally, patient willingness to continue using the wearable sensor for sleep monitoring is assessed. This evaluation helps determine the practicality and acceptance of the technology in real-world rehabilitation settings, providing insights into its potential for long-term use in clinical practice.

Workers with shoulder musculoskeletal disorders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent obtained.
  • Age ≥ 18 years.
  • Good understanding of spoken and written Italian.
  • Diagnosis of shoulder musculoskeletal disorders.
  • Employment in a physically demanding job requiring frequent upper limb activity.
  • Workers scheduled to undergo orthopedic shoulder surgery.
  • Workers who have accepted the surgical treatment.

You may not qualify if:

  • Patients with sleep disorders.
  • Patients undergoing pharmacological treatments that could potentially affect sleep patterns (e.g., antidepressants, hypnotics, and stimulants).
  • Failure to sign informed consent.
  • Patients with neuromuscular diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Italy, 00128, Italy

Location

MeSH Terms

Conditions

Musculoskeletal DiseasesShoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 12, 2025

First Posted

March 3, 2025

Study Start

March 3, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The ownership of the data is of the promoter and shared with the investigators and will be managed according to the agreements between the participating institutions and with the researchers. Data Property belongs to Fondazione Policlinico Universitario Campus Bio-Medico. The personnel involved in this study will have access to all data. In agreement with the ICH-GCP, the principal investigator of the study agrees to produce a report on the study, share all the data collected as described in the Protocol, and ensure that the data are reported responsibly and consistently. The transmission or dissemination of data through scientific publications and/or presentations in congresses, conferences, seminars, and participation in multicenter studies will take place exclusively following a purely statistical processing of the same, or in any case, in an anonymous form.

Locations